BIOSINO BIO-TEC (08247) affiliated Zhongsheng Jinan independently developed ZS-2000 fully automatic biochemical analyzer has obtained the medical device registration certificate and has been listed on the market.
China Life Sciences North Control Biotechnology (08247) announced that its subsidiary, China Life Medical Device Technology (Jinan) Co., Ltd. (China Life Jinan), has independently developed the ZS-2000 fully automatic biochemical analyzer, which has recently obtained the Chinese medical device registration certificate (registration certificate number: Lu Xie Zhu Jun 20262220227) issued by the Shandong Province Drug Administration. The acquisition of this registration certificate signifies that the product is now eligible for legal sales and use within China.
BIOSINO BIO-TEC (08247) announced that its subsidiary company Zhongsheng Medical Instrument Technology (Jinan) Co., Ltd. has independently developed the ZS-2000 fully automatic biochemical analyzer, which has recently obtained the Chinese Medical Device Registration Certificate (Registration Certificate Number: Lu Xie Zhu Zheng 20262220227) issued by the Shandong Provincial Drug Administration. The acquisition of this registration certificate signifies that the product is qualified for legal sales and use in China.
The ZS-2000 fully automatic biochemical analyzer is mainly used for clinical biochemical testing and can be widely applied in hospital laboratories, third-party medical laboratories, and other medical testing institutions. It features high throughput, automation, and intelligence, which helps to improve testing efficiency and reduce operating costs.
The acquisition of this registration certificate not only enhances the group's technical strength in the high-end biochemical analyzer field but also indicates the continuous improvement of the group's overall "instrument + reagent" solution, which helps to enhance the market competitiveness and brand influence of the group's products.
In addition, the Board of Directors believes that the successful launch of the ZS-2000 fully automatic biochemical analyzer and the cooperation to launch the ZS-8600 biochemical immunoinstrument will help the group further expand the domestic medical testing market, promote the sales of related supporting reagent products, and align with the group's long-term development strategy.
Related Articles

US Stock Market Move | Collaborating with NVIDIA Corporation to expand edge AI applications, BlackBerry Limited (BB.US) soared more than 14% in early trading.

Susquehanna: Data center demand drives semiconductor industry uptrend, raises target prices for Coherent and other companies.
.png)
US Stock Market Move | Most Star Tech Stocks fall Intel Corporation (INTC.US) drop over 3%
US Stock Market Move | Collaborating with NVIDIA Corporation to expand edge AI applications, BlackBerry Limited (BB.US) soared more than 14% in early trading.

Susquehanna: Data center demand drives semiconductor industry uptrend, raises target prices for Coherent and other companies.

US Stock Market Move | Most Star Tech Stocks fall Intel Corporation (INTC.US) drop over 3%
.png)
RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


